Last year, an estimated 2.3 million people were diagnosed with breast cancer.
Inherited gene mutations, known as BRCA 1-2, are found in about 5% of all breast cancer patients. A woman who tests positive for the BRCA 1-2 gene has a 60% to 70% chance of developing breast cancer in her lifetime. These patients are also 1.5 times more likely to have a recurrence of the cancer.
Researchers say the results of a stage three clinical trial may mean more options for these patients diagnosed at an early stage.
Andrea Ludema has more in today’s Healthy Living.
© 2023 - 910 Media Group
